Skip to content
Home/Companies/Biotech/Novos

Novos

Biotech·United States·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Novos?

Novos is currently owned by Unilever Ventures through Unilever Ventures (Evergreen) (2002 vintage), since 2026.

Hand-verified · updated 2026-08-02

Unilever Ventures
Investor
Unilever Ventures
Unilever Ventures (Evergreen) · 2002 · Evergreen

Key facts

HQUnited States
SectorBiotech
StatusActive

More from Unilever Ventures (Evergreen)

Other portfolio companies in the same fund.

Secret Alchemist
Active
ConsumerIndia· 2026
inde wild
Active
ConsumerUnited States· 2025
RAS Luxury Skincare
Active
ConsumerIndia· 2025
Arata
Arata
Active
ConsumerIndia· 2024
ClayCo Cosmetics
ClayCo Cosmetics
Active
ConsumerIndia· 2024
Luna Daily
Luna Daily
Active
ConsumerUK· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Novos

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Novos.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue